The only cervical device
clinically proven to reduce pain during transcervical procedures
CarevixTM is a single-use cervical stabilizer, engineered with vacuum technology, fully designed to deliver atraumatic transcervical access
Benefits
![Group 1267 Group 1267](https://e9rj3btxfoi.exactdn.com/wp-content/uploads/Group-1267.png?strip=all&lossy=1&ssl=1)
Gentle
![Group 1267 Group 1267](https://e9rj3btxfoi.exactdn.com/wp-content/uploads/Group-1267.png?strip=all&lossy=1&ssl=1)
Intuitive
![Group 1267 Group 1267](https://e9rj3btxfoi.exactdn.com/wp-content/uploads/Group-1267.png?strip=all&lossy=1&ssl=1)
Versatile
![aspivix_MG_0208 aspivix_MG_0208](https://e9rj3btxfoi.exactdn.com/wp-content/uploads/aspivix_MG_0208.png?strip=all&lossy=1&ssl=1)
Features
Clinical Evidence
ADVANCE Women Study (Atraumatic Device using VAcuum Technology for CErvical Procedures in Women)
![Group 1707@2x Group 1707@2x](https://e9rj3btxfoi.exactdn.com/wp-content/uploads/Group-1707@2x.png?strip=all&lossy=1&ssl=1)
Study Format
Randomized controlled trial (RCT), comparing the efficacy and safety of Aspivix device and the standard of care (tenaculum) in intrauterine contraception devices (IUD) procedures.
Primary Endpoint
Patient-reported pain scores (VAS) at specific time points during IUD insertion procedure.
![2Icon_Light-Yellow-Dark-Magenta_12 copy 2Icon_Light-Yellow-Dark-Magenta_12 copy](https://e9rj3btxfoi.exactdn.com/wp-content/uploads/2Icon_Light-Yellow-Dark-Magenta_12-copy.png?strip=all&lossy=1&ssl=1)
2 Centers in Switzerland
- University Hospital of Lausanne (CHUV)
- University Hospitals of Geneva (HUG)
Clinical Investigators
- Prof Patrice Mathevet, CHUV
- Dr. Hélène Legardeur, CHUV
- Dr. Michal Yaron, HUG
- Dr. Bastien Barcellini, HUG
- Dr. Farida Akhoundova, HUG
![2Icon_Light-Yellow-Dark-Magenta_6 copy@2x 2Icon_Light-Yellow-Dark-Magenta_6 copy@2x](https://e9rj3btxfoi.exactdn.com/wp-content/uploads/2Icon_Light-Yellow-Dark-Magenta_6-copy@2x.png?strip=all&lossy=1&ssl=1)
Status
Enrollment completed in February 2022
Results
Preliminary Results presented at European Society of Contraception in May 2022 - Link to the Press Release
For CLINICAL STUDIES WITH Aspivix Device please visit ClinicalTrials.gov.
Clinical Applications
![aspivix_MG_0022 aspivix_MG_0022](https://e9rj3btxfoi.exactdn.com/wp-content/uploads/aspivix_MG_0022-scaled.jpg?strip=all&lossy=1&ssl=1)
Carevix is indicated for use in various transcervical procedures, such as:
Are you interested in
being part of the change?